Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhejiang Nhu CoSZSE:002001 -1.38%98 Gross Margin % is 45.45% as of Jun. 2026, which is 1% above its 10-year median of 45.05. GuruFocus rates SZSE:002001 with a GF Score™ of 98/100 and a GF Value™ of ¥28.59 (Fairly Valued). The stock has 3 warning signs investors should review. Among 940 Drug Manufacturers companies, Zhejiang Nhu Co ranks worse than 57.45% on this metric.
Zhejiang Nhu Co Ltd gross margin has been in long-term decline. The average rate of decline per year is -3.5%.
The historical rank and industry rank for Zhejiang Nhu Co's Gross Margin % or its related term are showing as below:
SZSE:002001'
s Gross Margin % Range Over the Past 10 Years
Min: 32.98 Med: 45.05 Max: 54.17
Current: 43.87
During the past 13 years, the highestGross Margin % of Zhejiang Nhu Co was 54.17%. The lowest was 32.98%. And the median was 45.05%.
SZSE:002001's Gross Margin % is ranked worse than 57.45% of 940
companies
in the Drug Manufacturers industry
Industry Median: 48.515
vs SZSE:002001: 43.87
Zhejiang Nhu Co had a gross margin of 45.45% for the quarter that ended in Jun. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Zhejiang Nhu Co was -3.50% per year.
Zhejiang Nhu Co (SZSE:002001) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Zhejiang Nhu Co had a gross margin of 45.45% for the quarter that ended in Jun. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Zhejiang Nhu Co Gross Margin % Related Terms
Zhejiang Nhu Co Gross Margin % Historical Data
* Premium members only.
The historical data trend for Zhejiang Nhu Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Nhu Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhejiang Nhu Co Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhejiang Nhu Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Zhejiang Nhu Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Zhejiang Nhu Co (SZSE:002001) has a Gross Margin % of 45.45% as of Jun. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Zhejiang Nhu Co and its competitors. This is near median its historical median of 45.05. Over the past decade, Zhejiang Nhu Co's Gross Margin % has ranged from 32.98 to 54.17. According to the industry distribution chart, Zhejiang Nhu Co ranks #540 out of 940 companies in the Drug Manufacturers industry, placing it in the top 57.4%.
Is Zhejiang Nhu Co's Gross Margin % too high?
Zhejiang Nhu Co's current Gross Margin % of 45.45% is near median its 10-year median of 45.05. Over the past 10 years, this metric has ranged from a low of 32.98 to a high of 54.17. The Drug Manufacturers industry median Gross Margin % is 48.52. Zhejiang Nhu Co's value of 45.45% is 6.3% below this industry median. Based on the distribution chart, Zhejiang Nhu Co ranks #540 out of 940 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Zhejiang Nhu Co has a GF Score™ of 98/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Nhu Co's Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Zhejiang Nhu Co ranks #540 out of 940 companies for Gross Margin %. This places Zhejiang Nhu Co in the lower half of its industry. The industry median Gross Margin % is 48.52. Zhejiang Nhu Co's value of 45.45% is 6.3% below this benchmark. Historically, Zhejiang Nhu Co's own Gross Margin % has ranged from 32.98 to 54.17 over the past decade. While the company's 10-year median is 45.05 vs. the industry median of 48.52, Zhejiang Nhu Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.52, based on 940 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhejiang Nhu Co's current Gross Margin % of 45.45% is 6.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Zhejiang Nhu Co and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhejiang Nhu Co's current Gross Margin % is 45.45%, which is near median its own 10-year median of 45.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Nhu Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Nhu Co (SZSE:002001) is currently considered Fairly Valued. The stock's GF Value™ is ¥28.59, compared to a current price of ¥26.49 — trading 7.3% below its estimated fair value. The current Gross Margin % is 45.45%, which is near median its 10-year median of 45.05 and 6.3% below the Drug Manufacturers industry median of 48.52. Zhejiang Nhu Co's overall GF Score™ is 98/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Zhejiang Nhu Co (SZSE:002001), the current Gross Margin % is 45.45% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhejiang Nhu Co (SZSE:002001) Overvalued in 2026?
Based on GuruFocus' analysis, Zhejiang Nhu Co stock appears to be undervalued.
The current stock price of ¥26.49 is trading 7.3% below its estimated GF Value™ of ¥28.59.
GuruFocus considers Zhejiang Nhu Co to be Fairly Valued.
Key valuation signals for SZSE:002001:
Gross Margin %: 45.45% (near median its 10-year median of 45.05)
GF Value™: ¥28.59 vs. price of ¥26.49 (7.3% below fair value)
Industry Position: 6.3% below the Drug Manufacturers median (#540 of 940)
No single metric tells the full story. See the SZSE:002001 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhejiang Nhu Co Ltd is a China-based company engaged in the manufacture and sales of pharmaceuticals, health protection products, pharmaceutical intermediates, fragrances, food additives, and feed additives. The company's active pharmaceutical ingredient products cover various areas such as Cardiovascular, Anti-AIDS, Anti-cancer, and Anti-bacterial, with key products such as Latamoxef Sodium, Flomoxef Sodium, Hydrochloride Moxifloxacin, Artemisinin series, Calcium Keto acid series, Vitamin A/E/D3, and coenzyme Q10, and others. The other business areas are Aroma chemicals, Polymers, and Nutrition. The organization markets its products in China and internationally.
98GF Score
Get the complete analysis for SZSE:002001
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:002001 has been successfully added to your 
